Skip to main content

Table 1 Relationship between RelB expression and clinicopathological characteristics

From: The nuclear transcription factor RelB functions as an oncogene in human lung adenocarcinoma SPC-A1 cells

Characteristics

RelB expression

p value

High

n = 69 (53.1%)

Low

N = 61 (46.9%)

Gender

  

0.650

 Male

31 (55.3)

25 (44.7)

 

 Female

38 (51.3)

36 (48.7)

 

Age

  

0.590

 Mean ± SD

60.56 ± 10.15

60.15 ± 10.31

 

 Range

33–83

38–87

 

Smoking

  

0.603

 Yes

23 (50.0)

23 (50.0)

 

 No

46 (54.8)

38 (45.2)

 

Histology

  

0.948

 ADC

49 (53.2)

43 (46.8)

 

 SCC

20 (52.6)

18 (47.7)

 

Degree of differentiation

  

0.116

 Low

26 (66.7)

13 (33.3)

 

 Middle

38 (48.1)

41 (51.9)

 

 High

5 (41.7)

7 (58.3)

 

Depth of tumor invasion

  

0.010a

 T1

15 (36.6)

26 (63.4)

 

 T2

31 (52.5)

28 (47.5)

 

 T3

14 (73.7)

5 (26.3)

 

 T4

9 (81.8)

2 (18.2)

 

Lymph node metastasis

  

0.048a

 N0

24 (44.4)

30 (55.6)

 

 N1

35 (54.7)

29 (45.3)

 

 N2

10 (83.3)

2 (16.7)

 

Distant metastases

  

0.006a

 No

56 (48.7)

59 (51.3)

 

 Yes

13 (86.7)

2 (13.3)

 

TNM stage

  

< 0.001a

 I

13 (33.3)

26 (66.7)

 

 II

21 (42.9)

28 (57.1)

 

 III

22 (81.5)

5 (18.5)

 

 IV

13 (86.7)

2 (13.3)

 
  1. ADC adenocarcinoma, SCC squamous cell carcinoma, NSCLC non-small cell lung cancer
  2. a The difference had statistically significance